Search research articles
Contact Us
Filters
Showing results (21-30 of 45) with videos related to
Page
of 5
Sort By:
Sexual Medicine Reviews
|
July 2, 2018
Cardiovascular Safety of Phosphodiesterase Type 5 Inhibitors After Nearly 2 Decades on the Market
Robert A Kloner, Irwin Goldstein, Michael G Kirby, et al.
Journal of the American Academy of Nurse Practitioners
|
June 9, 2011
Optimizing treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction: opening windows to enhanced sexual function and overall health
Richard Sadovsky, Gerald B Brock, Mikel Gray, et al.
The Journal of Sexual Medicine
|
January 23, 2010
Cancer and sexual problems
Richard Sadovsky, Rosemary Basson, Michael Krychman, et al.
Postgraduate Medicine
|
July 26, 2008
Dispelling the myths about omega-3 fatty acids
Richard Sadovsky, Nancy Collins, Ann P Tighe, et al.
Urology
|
August 11, 2004
Erection quality scale: initial scale development and validation
John Wincze, Raymond Rosen, Culley Carson, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|
June 6, 2013
The Greater Metropolitan Medical Alumni Council (GMMAC): the realization of a need
Elise Belilos, James M Oleske, Norman B Medow, et al.
The Journal of Sexual Medicine
|
January 23, 2010
Recommendations for the clinical evaluation of men and women with sexual dysfunction
Dimitrios Hatzichristou, Raymond C Rosen, Leonard R Derogatis, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
May 10, 2018
A New Perspective on the Nitrate-Phosphodiesterase Type 5 Inhibitor Interaction
Robert A Kloner, Paul Goggin, Irwin Goldstein, et al.
The Journal of Sexual Medicine
|
January 21, 2006
The efficacy of tadalafil in clinical populations
Ronald W Lewis, Richard Sadovsky, Ian Eardley, et al.
The Journal of Sexual Medicine
|
January 21, 2006
Clinical evaluation and management strategy for sexual dysfunction in men and women
Dimitrios Hatzichristou, Raymond C Rosen, Gregory Broderick, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 45) with videos related to
Sort By:
Page
of 5
Sexual Medicine Reviews
|
July 2, 2018
Cardiovascular Safety of Phosphodiesterase Type 5 Inhibitors After Nearly 2 Decades on the Market
Robert A Kloner, Irwin Goldstein, Michael G Kirby, et al.
Journal of the American Academy of Nurse Practitioners
|
June 9, 2011
Optimizing treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction: opening windows to enhanced sexual function and overall health
Richard Sadovsky, Gerald B Brock, Mikel Gray, et al.
The Journal of Sexual Medicine
|
January 23, 2010
Cancer and sexual problems
Richard Sadovsky, Rosemary Basson, Michael Krychman, et al.
Postgraduate Medicine
|
July 26, 2008
Dispelling the myths about omega-3 fatty acids
Richard Sadovsky, Nancy Collins, Ann P Tighe, et al.
Urology
|
August 11, 2004
Erection quality scale: initial scale development and validation
John Wincze, Raymond Rosen, Culley Carson, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|
June 6, 2013
The Greater Metropolitan Medical Alumni Council (GMMAC): the realization of a need
Elise Belilos, James M Oleske, Norman B Medow, et al.
The Journal of Sexual Medicine
|
January 23, 2010
Recommendations for the clinical evaluation of men and women with sexual dysfunction
Dimitrios Hatzichristou, Raymond C Rosen, Leonard R Derogatis, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
May 10, 2018
A New Perspective on the Nitrate-Phosphodiesterase Type 5 Inhibitor Interaction
Robert A Kloner, Paul Goggin, Irwin Goldstein, et al.
The Journal of Sexual Medicine
|
January 21, 2006
The efficacy of tadalafil in clinical populations
Ronald W Lewis, Richard Sadovsky, Ian Eardley, et al.
The Journal of Sexual Medicine
|
January 21, 2006
Clinical evaluation and management strategy for sexual dysfunction in men and women
Dimitrios Hatzichristou, Raymond C Rosen, Gregory Broderick, et al.
Page
of 5